Td Asset Management Inc Nkarta, Inc. Transaction History

Td Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$3.37 - $6.3 $34,374 - $64,260	10,200 Added 19.18%	63,384 $225,000
Q4 2022 Feb 06, 2023	BUY	$5.14 - $14.35 $89,436 - $249,690	17,400 Added 48.63%	53,184 $318,000
Q2 2022 Aug 04, 2022	BUY	$7.77 - $19.44 $66,744 - $166,989	8,590 Added 31.59%	35,784 $441,000
Q1 2022 May 10, 2022	SELL	$8.66 - $14.99 $82,512 - $142,824	-9,528 Reduced 25.95%	27,194 $309,000
Q4 2021 Feb 10, 2022	BUY	$12.79 - $26.88 $469,674 - $987,087	36,722 New	36,722 $564,000
Q2 2021 Aug 11, 2021	SELL	$23.94 - $36.68 $262,765 - $402,599	-10,976 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$31.33 - $59.61 $213,044 - $405,348	-6,800 Reduced 38.25%	10,976 $361,000
Q3 2020 Nov 10, 2020	BUY	$23.52 - $47.9 $418,091 - $851,470	17,776 New	17,776 $534,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $127M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.